The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.

Global HIV/AIDS Vaccine Enterprise · PLoS Med · 2005

review · Level V

Where this comes from

Abstract

The development of an HIV vaccine remains one of the most difficult challenges confronting biomedical research today. A new international collaboration shares its plan to address the challenge

Medical subject headings